Hypothalamic and amygdalar cell lines differ markedly in mitochondrial rather than nuclear encoded gene expression by Dhwanil A Dalwadi & Rosalie M Uht
Dalwadi and Uht BMC Genomics 2013, 14:413
http://www.biomedcentral.com/1471-2164/14/413RESEARCH ARTICLE Open AccessHypothalamic and amygdalar cell lines differ
markedly in mitochondrial rather than nuclear
encoded gene expression
Dhwanil A Dalwadi1 and Rosalie M Uht1,2*Abstract
Background: Corticotropin-releasing hormone (CRH) plays an important role in regulating the mammalian stress
response. Two of the most extensively studied neuronal populations that express CRH are in the hypothalamus and
amygdala. Both regions are involved in the stress response, but the amygdala is also involved in mediating
response to fear and anxiety. Given that both hypothalamus and amygdala have overlapping functions, but their
CRH-expressing neurons may respond differently to a given perturbation, we sought to identify differentially
expressed genes between two neuronal cell types, amygdalar AR-5 and hypothalamic IVB cells. Thus, we performed
a microarray analysis. Our hypothesis was that we would identify differentially expressed transcription factors,
coregulators and chromatin-modifying enzymes.
Results: A total of 31,042 genes were analyzed, 10,572 of which were consistently expressed in both cell lines at a
95% confidence level. Of the 10,572 genes, 2,320 genes in AR-5 were expressed at ≥ 2-fold relative to IVBs, 1,104
genes were expressed at ≥2-fold in IVB relative to AR-5 and 7,148 genes were expressed at similar levels between
the two cell lines. The greatest difference was in six mitochondrial DNA-encoded genes, which were highly
abundant in AR-5 relative to IVB cells. The relative abundance of these genes ranged from 413 to 885-fold
according to the microarray results. Differential expression of these genes was verified by RTqPCR. The differentially
expressed mitochondrial genes were cytochrome b (MT-CYB), cytochrome c oxidase subunit 1 and 2 (MT-CO1 and
MT-CO2) and NADH-ubiquinone oxidoreductase chain 1, 2, and 3 (MT-ND1, MT-ND2, MT-ND3).
Conclusion: As expected, the array revealed differential expression of transcription factors and coregulators;
however the greatest difference between the two cell lines was in genes encoded by the mitochondrial genome.
These genes were abundant in AR-5 relative to IVBs. At present, the reason for the marked difference is unclear. The
cells may differ in mtDNA copy number, number of mitochondria, or regulation of the mitochondrial genome. The
specific functions served by having such different levels of mitochondrial expression have not been determined. It
is possible that the greater expression of the mitochondrial genes in the amygdalar cells reflects higher energy
requirements than in the hypothalamic cell line.
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Any change that results in homeostatic imbalance due
to exogenous or endogenous stimuli may be considered
a stressor. This, in turn, initiates a complex signaling cas-
cade of stress-inducible proteins and transcription factors
that serves to return the cell to homeostatic conditions.
The appropriate cellular response is determined by the
ability to successfully meet the physiological demands of
stress, and is paramount for survival. This is a multi-system
process, and in mammals, activation of the hypothalamic-
pituitary-adrenal (HPA) axis plays a key role.
The stress-response can be divided into three categories:
behavioral, autonomic and hormonal [1]. The behavioral
response includes the skeletal motor response to a stres-
sor, whereas the autonomic response, mediated though
the sympathetic nervous system, increases activity of
organs, such as the heart and lungs, for fight or flight
responses [1]. The hormonal response provides fuel for
such activities. The neuropeptide corticotropin-releasing
hormone (CRH) is believed to be involved in all three
stress-responses, involving different brain regions [1]. The
behavioral response is initiated in part by the amygdala,
which contains CRH-expressing neurons and mediates
fear-associated behavior such as fight or flight. CRH neu-
rons in the amygdala and paraventricular nucleus project
to the locus coeruleus, which in turn sends descending
fibers to the brainstem, which is responsible for auto-
nomic responses ([2,3] and references therein). The hor-
monal response is initiated by activation of the HPA
axis. This activation leads to the release of CRH from
the paraventricular nucleus of the hypothalamus (PVH)
into the portal circulation of the median eminence. In
contrast, the amygdalar CRH system is more sensitive
to psychological stressor than the PVH CRH system
given that psychological stress increases CRH levels in
the amygdala but not in the PVH [4]. However, CRH
increase in the amygdala does not elicit a hormonal
response and may be contributing to psychological stress-
evoked behavior such as hyperarousal [4]. Due to the
wide range of effects of CRH, its expression needs to be
tightly regulated, and its dysregulation is associated with
profound neuropsychiatric consequences, in particular,
mood disorders such as depression and anxiety [5].
In this study, we utilized hypothalamic (IVB) and
amygdalar (AR-5) rat clonal cell lines. Particularly for
such a heterogeneous tissue as the CNS, in vitro systems
are invaluable for studying signaling mechanisms and
gene regulation [6]. The hypothalamic IVB cell line is an
immortalized rat fetal hypothalamic cell line developed
from rat-primary hypothalamic culture by retroviral
transformation [7]. These cells express CRH mRNA, ex-
hibit CRH immunoreactivity, and co-express vasopressin
and Type-1 CRH receptors, suggesting a parvocellular
phenotype [7]. The amygdalar AR-5 cell line was preparedthe same way as the IVBs and is similar to primary
amygdalar cell culture in response to known regulators
of amygdalar CRH [8].
The aim of this study was to identify differentially
expressed genes in the two cell types at basal levels. Our
hypothesis was that the most significant difference between
the two lines would be a differential expression of transcrip-
tion factors, coregulators and/or chromatin-modification
enzymes.
Methods
Cell culture and treatment
Rat AR-5 amygdalar and IVB hypothalamic cell lines were
used in this experiment. AR-5 and IVB cells were cultured
in phenol red-free DMEM/F12 media (Hyclone) supple-
mented with 10% newborn calf serum (NCS) (Gemini
Bioproducts), 2 mM L-glutamine, 1 mM sodium pyruvate,
0.1 mM nonessential amino acids, and 100 U/mL penicillin/
streptomycin (all from Cellgro, Mediatech Inc.).
For the microarray experiment, 105 cells were plated
on Nunc 6-well plates (Nalge Nunc International). After
24 hours, cells were washed with PBS (137 mM NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4 and 1.47 mM KH2PO4;
pH 7.4) and maintained in media containing charcoal-
stripped NCS for 48 hours.
RNA isolation
Total RNA was extracted using Tri-reagentW (MRC Inc.)
according to manufacturer’s protocol. Briefly, cells were
suspended in 1 mL of Tri-reagent and incubated at room
temperature for 5 minutes. Subsequently, 0.2 mL of chloro-
form was added and the homogenate was shaken vigor-
ously for 15 seconds and incubated at room temperature
for 10 minutes. Samples were centrifuged at 12,000 g for
15 minutes at 4°C. The aqueous phase was then combined
with equal volume of isopropanol, incubated at room
temperature for 10 minutes and centrifuged at 12,000 g
for 15 minutes at 4°C. The resulting RNA pellet was
washed with 1 mL of 75% ethanol, centrifuged (at 7500 g,
5 min, 4°C), air-dried for 10 minutes and dissolved in
20 μL of nuclease-free water (Sigma). The RNA concen-
tration was measured using a Bio-tek plate reader, and
RNA integrity was assessed using an Agilent2100 RNA
nano-chip.
Gene expression analysis
Sample labeling, hybridization and data extraction was
performed by the UTSW microarray core facility; the
Affymetrix rat genome 230 2.0 array was used. ArrayStar
(DNASTAR, Inc.) was used to obtain the gene list and
compare the relative gene expression between the AR-5
and IVB cell lines. The experiment was performed in
triplicate, and genes that were consistently expressed in
the two cell lines at a 95% confidence level were analyzed
Table 1 List of primers used to verify the expression of 6
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identify functional groups of genes that are abundant in
each cell line.
Measure of differential expression was calculated by set-
ting the IVB expression levels as baseline and is expressed
as fold difference. Genes expressed at 2-fold or greater
were considered to be expressed at a higher level in the
AR-5 and genes expressed at 0.5 fold or less were consid-
ered to be abundant in the IVBs.
The gene expression data was combined with the in-
formation from the Gene Ontology (GO) database, using
the Database for Annotation, Visualization and Integrated
Discovery (DAVID) bioinformatics database [9,10]. DAVID
is a functional annotation tool that allows the investigator
to assign empirically determined biological functions to
a large set of gene list. The GO database (a tool within
DAVID) was used to identify biological processes asso-
ciated with the genes in the 95% confidence level that
met the 2-fold cutoff criteria. To search for reported phys-
ical and/or functional associations between the enriched
protein coding genes, the data was analyzed using the
Search Tool for the Retrieval of Interacting Genes/
Proteins (STRING) database [11].Validation of microarray results by RTqPCR
Complementary DNA (cDNA) was synthesized using the
Verson cDNA kit (Thermo Fisher Scientific), following
the manufacturer’s protocol with the following modifica-
tions. A 1 μg sample of total RNA was used as the tem-
plate, reverse gene specific primers were used and cDNA
was synthesized at 47.8°C for 1 hour. RTqPCR was
performed using the BIORAD thermocycler to compare
the expression levels of MT-CO1, MT-CO2, MT-CYB,
MT-ND1, MT-ND2 and MT-ND3 between the two cell
lines; 60S ribosomal protein L27a (RpL27a) was used as
the reference gene. Primers used for each gene can be
found in Table 1.
The cycling parameters were: initial melting step at
95°C for 15 sec, and amplification at 95°C for 5 sec, then
60°C for 30 sec. The amplification steps were repeated
for a total of 40 cycles.
The ΔΔC(t) method was used to obtain the fold differ-
ence. The C(t) values for IVBs were used as the reference
value and the data was normalized to RpL27a.Statistical analysis
Three biological replicates were analyzed for each cell line.
A statistical cutoff of 5% False Discovery Rate (FDR) was
generated with a moderate t-test with Benjamini Hochberg
multiple testing correction. A 2-fold cutoff was also
applied to identify differentially expressed genes.
For the RTqPCR data, the data represents the average
of 11 biological replicates, the statistical significance wasdetermined by performing one-tailed student’s t-test and
p ≤ 0.05 was considered significant.
To measure gene-enrichment in biological processes,
Expression Analysis Systematic Explorer (EASE) score
was used, which is a modified Fisher Exact p-value. An
EASE score of < 0.05 was used to identify significantly
enriched GO terms.
Results and discussion
Comparison between AR-5 and IVB gene expression
patterns
An Affymetrix microarray platform was used to obtain a
gene expression profile of AR-5 and IVB cell lines. As
explained previously, the expression levels of AR-5 and
IVB were compared, and genes with a fold difference
of ≥ 2 were considered relatively abundant in AR-5, and
genes with a fold difference of ≤ 0.5 were considered
abundant in IVB. A total of 31,042 genes were analyzed
on the array, out of which 10,572 genes were consistently
expressed in the two cell lines at a 95% confidence level.
Out of the 10,572 genes, 2,320 genes were expressed at
≥2-fold, relative to expression in IVBs; 1,104 genes were
expressed at ≥2-fold, relative to expression in AR-5 and
7,148 genes were expressed at similar levels in the two
cell lines. Figure 1A shows the hierarchical clustering of
all the genes in the 95% confidence level, where red
indicates highly expressed genes and green indicates
low expression of genes.
Out of the 2,320 genes that were comparatively abun-
dant in AR-5s, 6 genes had a fold difference of >410
(Figure 1B). These are Cytochrome b (MT-CYB), Cyto-
chrome c oxidase subunit 1 (MT-CO1), Cytochrome c
oxidase subunit 2, (MT-CO2), NADH-ubiquinone oxi-
doreductase chain 1, 2 and 3 (MT-ND1, 2 and 3,
Figure 1 (See legend on next page.)
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Figure 1 Hierarchal clusters showing the relative abundance of genes in AR-5 cells as compared to abundance of genes in IVB cells
(Red = high expression, Green = low expression). (A) Expression of 10,572 genes that were consistently expressed in the two cell lines at a
95% confidence level from 3 biological replicates. (B) A subcluster of genes that are highly expressed in AR-5, relative to IVBs. The cluster outlined
in the box represents the mitochondrial DNA-encoded genes: MT-CO1, MT-CO2, MT-CYB, MT-ND1, MT-ND2 and MT-ND3. (C) Subcluster of genes
highly expressed in IVBs relative to AR-5 s.
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drial genome. Out of the 1,104 genes that were compara-
tively abundant in IVBs, 6 genes had a fold difference of
> 80 (Figure 1C). These genes are sorting nexin 12 (Snx12),
gremlin 1 (Grem1), actin gamma 1 (Actg1), collectin
sub-family member 12 (Colec12), eukaryotic translation
elongation factor 2 (Eef2) and matrix metallopeptidase 2
(Mmp2). We focused on the 6 mitochondrial genes be-
cause there was a >410 fold difference in mitochondrial
genes between the two cell lines.
To validate the microarray results, the relative expression
of the 6 mitochondrial genes was analyzed by RTqPCR.
The data was normalized to RpL27a, and the results shown
in Figure 2 confirm the finding of the microarray results.
The greatest difference in expression is evident for
MT-ND2, which is expressed at 107-fold greater in
AR-5, relative to the IVB cell line.
Mitochondria play a crucial role in cellular physiology
and are among the first organelles to respond to various
stressors that might influence cell homeostasis. Adaptive
stress response involves changes in mitochondrial func-
tions, which enable them to adjust thermogenesis, bio-
energetics, oxidative and apoptotic responses [12]. TheFigure 2 Verification of selected genes from the microarray data by R
or greater in the AR-5 line as compared to the IVB line, were selected for v
was normalized to 60S ribosomal protein L27a (RpL27a). All p-values are ≤
oxidase subunit 1, (MT-CO2) Cytochrome c oxidase subunit 2, (MT-CYB) Cytoc
NADH ubiquinone oxidoreductase chain 2, and (MT-ND3) NADH ubiquinoneHPA axis plays a central role in the neuroendocrine re-
sponse to stress, thus it was surprising to see such marked
differences in the expression of oxidative phosphorylation
(OXPHOS) genes in the amygdalar cell line rather than in
a cell line representative of the neuroendocrine compo-
nent of the HPA axis (PVH). Cell-specific variation in
gene expression is expected but a 400-fold or greater
difference is very unusual.
It has been established that mitochondrial density dif-
fers between tissues [13]. Thus, it is not surprising that
a high energy-consuming organ like the brain has a high
mitochondrial density. When regional variation in mouse
brain was assessed in 39 brain regions of adult mice, no
significant difference was detected between the amygdala
and hypothalamus, even though there were differences
between other regions like the ventral tegmental area
and cerebellum [14]. Several reasons may be offered for
the discrepancy between the latter finding and our data,
such as an in vitro vs. in vivo settings and species differ-
ences of mice vs. rats. In addition, our two leading the-
ories are, first, that in the rat brain there is a difference
in mitochondrial DNA copy number and/or the total
number of mitochondria between the amygdala and theTqPCR. The six mitochondrial genes that were expressed at 400-fold
erification. The ΔΔCT method was used for quantitation and the data
0.0005. The genes verified by RTqPCR were (MT-CO1) Cytochrome c
hrome b, (MT-ND1) NADH ubiquinone oxidoreductase chain 1, (MT-ND2)
oxidoreductase chain 3.
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regulation of mitochondrial genes. We will be testing
these theories.
The mitochondrial genome consists of ~16 kb and
codes for 37 genes. Of these, 13 are protein-coding genes
and form subunits of the electron transport chain (ETC).
The ETC consists of 5 complexes and a total of 97 genes
make up the ETC, of which 84 are encoded by the nuclear
genome. The expression of the nuclear-encoded mito-
chondrial genes did not differ between the two cell lines,
as per our criteria for differential expression (Additional
file 1: Table S1, category “Electron Transport Chain”). This
underscores that mitochondria are signal contributors to
the differences between the two cell lines.
Gene ontology
To identify the biological processes associated with the
genes from the microarray, differentially expressed genes
were interrogated using the DAVID program. A total of
235 biological processes were enriched in AR-5s, 306
were enriched in IVBs and of these, 38 were common to
both cell types. Figure 3 shows an example of genes that
fell into two biological processes (GO Terms) that were
common to both cell lines, “response to organic substances”
and “regulation of transcription”. These terms were chosen
because they had an EASE score < 0.05 and containFigure 3 Genes expressed at ≥2-fold (as per microarray) in each cell l
bioinformatics tool. The graph shows an example of two biological proce
stimuli” and “regulation of transcription”. A fold-difference > 1 indicates hig
following genes are shown in the graph: (Aldh3a1) aldehyde dehydrogena
c oxidase subunit Vb, (MT-CYB) cytochrome b, (Dnajb5) DnaJ (Hsp40) homo
C member 3, (E2f1) E2F transcription factor 1, (Fos) FBJ osteosarcoma onco
histone deacetlyase 6, (Hsp90ab1) heat shock protein 90 kDa alpha class B me
(Kdm1) Lysine (K)-specific demethylase 1, (kdm3a) lysine (K)-specific demethyl
liver x receptor alpha, (Nr2f2) COUP transcription factor 2, (Nr3c2) mineralocornuclear receptors, as well as genes involved in the ETC,
CRH regulation, stress responses, and responses to cor-
ticosteroid stimuli. Figure 3 also demonstrates that even
in biological processes common to both cell lines, the
expression pattern is very different between the two. It
is interesting to note that with the exception of Hsp90ab1,
the AR-5 cells express more heat shock and electron
transport genes like DnaJ (Hsp40) homolog subfamily B
member 5 (Dnajb5), DNAJ (Hsp40) homolog subfamily
C member 3 (Dnajc3) and cytochrome c oxidase subunit
Vb (Cox5B), MT-CYB, MT-ND1, MT-ND3. In distinc-
tion, the IVB cell line expresses genes involved in cor-
ticosteroid metabolism, such as aldehyde dehydrogenase
3 family member A1 (Aldh3a1) and nuclear receptors
such as, liver X receptor alpha (Nr1h3), COUP transcrip-
tion factor 2 (Nr2f2) and the mineralocorticoid receptor
(Nr3c2).
Of interest with respect to glucocorticoid down regulation
of gene expression is that the activator protein-1 (AP-1)
proteins Fos and Jun are differentially expressed between
the two lines. fos, is expressed approximately 10.2 fold
greater in AR-5 s than in IVB, whereas jun is expressed
approximately 2.2-fold greater in IVB than in AR-5 s
(Figure 3). It is known that GRs down-regulate gene ex-
pression through AP-1 family members, and Diamond
et al. showed that the relative abundance of Jun and Fosine, relative to each other, were analyzed using the DAVID
sses (GO Terms) that have an EASE score < 0.05: “response to organic
h expression in AR-5 and < 1 indicates high expression in IVB cells. The
se 3A1, (Avpr1a) Arginine vasopressin receptor 1A, (Cox5B) cytochrome
log subfamily B member 5, (Dnajc3) DnaJ (Hsp40) homolog subfamily
gene, (GRLF1) glucocorticoid receptor DNA binding factor 1, (Hdac6)
mber 1, (Jun) Jun proto-oncogene, (KAT5) Lysine (K) acetyltransferase 5,
ase 3A, (MT-ND1-3) NADH-ubiquinone oxidoreductase chain 1–3, (Nr1h3)
ticoid receptor, (sgk1) serum/glucocorticoid regulated kinase 1.
Table 2 List of select biological processes with an EASE score of < 0.05, and their corresponding genes
Category Gene symbol Name AR-5/IVB EASE score
Response to hormone stimulus Adcy5 adenylate cyclase 5 0.394 8.50E-06
Adcy8 adenylate cyclase 8 (brain) 0.479
Adm Adrenomedullin 0.108
Aldh3a1 aldehyde dehydrogenase 3 family, member A1 0.073
Arnt2 aryl hydrocarbon receptor nuclear translocator 2 0.223
Avpr1a arginine vasopressin receptor 1A 0.356
Eif2b5 eukaryotic translation initiation factor 2B, subunit 5 epsilon 0.409
Ghr growth hormone receptor 0.155
Gja1 gap junction protein, alpha 1 0.485
Gpx3 glutathione peroxidase 3 0.246
Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) 0.226
Hmox1 heme oxygenase (decycling) 1 0.413
Insig2 insulin induced gene 2 0.447
Kcnma1 potassium large conductance calcium-activated channel, subfamily M,
alpha member 1
0.032
Kdm3a lysine (K)-specific demethylase 3A 0.439
lpin1 lipin 1 0.479
Nr1h3 nuclear receptor subfamily 1, group H, member 3 (liver X receptor alpha) 0.283
Sgk1 serum/glucocorticoid regulated kinase 1 0.293
Stat5b signal transducer and activator of transcription 5B 0.365
Stk11 serine/threonine kinase 11 0.471
Tgfb3 transforming growth factor, beta 3 0.412
Tlr4 toll-like receptor 4 0.138
Response to corticosteroid stimulus Adm Adrenomedullin 0.108 3.90E-02
Aldh3a1 aldehyde dehydrogenase 3 family, member A1 0.073
Avpr1a arginine vasopressin receptor 1A 0.356
Bmp4 bone morphogenetic protein 4 0.276
Cav1 caveolin 1, caveolae protein 0.454
Ghr growth hormone receptor 0.155
Gpx3 glutathione peroxidase 3 0.246
Kcnma1 potassium large conductance calcium-activated channel, subfamily M,
alpha member 1
0.032
Ptgs1 prostaglandin-endoperoxide synthase 1 0.213
Sgk1 serum/glucocorticoid regulated kinase 1 0.293
Tlr4 toll-like receptor 4 0.138
Response to estradiol stimulus Aldh1a1 aldehyde dehydrogenase 1 family, member A1 0.284 6.10E-03
Arnt2 aryl hydrocarbon receptor nuclear translocator 2 0.223
Bmp4 bone morphogenetic protein 4 0.276
CCND2 cyclin D2 0.013
Cst3 cystatin C 0.276
Gpx4 glutathione peroxidase 4 0.457
MAP1B mi crotubule-associated protein 1B 0.458
Pdgfra platelet derived growth factor receptor, alpha polypeptide 0.071
Pdgfrb platelet derived growth factor receptor, beta polypeptide 0.23
Stat5b signal transducer and activator of transcription 5B 0.365
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Table 2 List of select biological processes with an EASE score of < 0.05, and their corresponding genes (Continued)
Electron transport chain Cyb561d2 cytochrome b-561 domain containing 2 3.594 1.40E-05
Cyba cytochrome b-245, alpha polypeptide 2.186
Fads1 fatty acid desaturase 1 2.307
GLRX2 glutaredoxin 2 2.158
MT-CO1 Cytochrome c oxidase subunit 1 426.042
MT-CO2 Cytochrome c oxidase subunit 2 477.423
MT-CYB Cytochrome b 413.38
MT-ND1 NADH-ubiquinone oxidoreductase chain 1 874.324
MT-ND2 NADH-ubiquinone oxidoreductase chain 2 885.655
MT-ND3 NADH-ubiquinone oxidoreductase chain 3 789.947
Ndufa10 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 2.972
Ndufa11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 3.222
Ndufs1 NADH dehydrogenase (ubiquinone) Fe-S protein 1 2.876
Ndufv2 NADH dehydrogenase (ubiquinone) flavoprotein 2 3.599
Sod2 superoxide dismutase 2, mitochondrial 5.725
Uqcrh ubiquinol-cytochrome c reductase hinge protein 2.46
Cellular response to stress
Apoe apolipoprotein E 2.945
8.20E-04
ATM ataxia telangiectasia mutated homolog (human) 2.803
Atrx alpha thalassemia/mental retardation syndrome X-linked
(RAD54 homolog, S. cerevisiae)
3.575
Bmpr2 bone morphogenetic protein receptor, type II (serine/threonine kinase) 3.772
Brca1 breast cancer 1 3.075
CCNH cyclin H 2.232
Chek1 CHK1 checkpoint homolog (S. pombe) 2.156
Cib1 calcium and integrin binding 1 (calmyrin) 2.176
Cryab crystallin, alpha B 2.567
Cxcl10 chemokine (C-X-C motif) ligand 10 3.003
Derl2 Der1-like domain family, member 2 2.218
DNA2 DNA replication helicase 2 homolog (yeast) 2.158
Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 2.058
Fads1 fatty acid desaturase 1 2.307
Fam175a family with sequence similarity 175, member A 2.861
Fancd2 Fanconi anemia, complementation group D2 2.245
Fen1 flap structure-specific endonuclease 1 2.251
Fos FBJ osteosarcoma oncogene 10.247
H2afx H2A histone family, member X 3.259
Hdac1 histone deacetylase 1 4.309
Hdac6 histone deacetylase 6 3.035
HFE hemochromatosis 6.684
Irak1 interleukin-1 receptor-associated kinase 1 2.25
Kat5 K(lysine) acetyltransferase 5 2.098
Kif22 kinesin family member 22 2.173
Nuak2 NUAK family, SNF1-like kinase, 2 2.981
Pdcd6ip programmed cell death 6 interacting protein 2.537
Rad18 RAD18 homolog (S. cerevisiae) 2.862
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Table 2 List of select biological processes with an EASE score of < 0.05, and their corresponding genes (Continued)
Rad50 RAD50 homolog (S. cerevisiae) 2.745
Rad51 RAD51 homolog (S. cerevisiae) (RecA homolog, E. coli) 3.009
RGD1307983 similar to HSPC043 protein 3.009
Rpain RPA interacting protein 2.024
SLK STE20-like kinase (yeast) 2.698
Sod2 superoxide dismutase 2, mitochondrial 5.725
Sp100 SP100 nuclear antigen 5.382
Stradb amyotrophic lateral sclerosis 2 (juvenile) chromosome region,
candidate 2 (human)
2.154
Trip13 thyroid hormone receptor interactor 13 2.417
Uhrf1 ubiquitin-like with PHD and ring finger domains 1 2.804
Usp1 ubiquitin specific peptidase 1 5.541
Xbp1 X-box binding protein 1 3.932
Genes expressed at ≥ 2 fold are more abundant in AR-5 and genes expressed at ≤ 0.5-fold are highly expressed in IVB cells. A complete list of genes in the
above mentioned biological processes can be found in Additional file 1: Table S1 and biological processes associated with a gene can be found in
Additional file 2: Table S2.
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determined whether the gene was activated or repressed
[15]. Thus, this difference in expression might play a
role in one of the differences seen in CRH neurons in
the amygdala and the hypothalamus. Specifically, gluco-
corticoids down-regulate CRH expression in the HPA-axis
motor neurons in the PVH, where as they up regulate it
in CRH neurons in the amygdala ([16], review).
The Table 2 shows additional biological processes that
are of interest, such as, response to hormone stimulus,
corticosteroid stimulus, estradiol stimulus, electron trans-
port chain, and cellular response to stress. For each term,
the genes identified in Table 2, are a subset of a larger list
that can be found in Additional file 1: Table S1. It should
also be noted that the genes listed in Table 2 and Figure 3
are not just associated with a single biological process and
a complete list of GO Terms associated with genes found
in Table 2 can be found in Additional file 2: Table S2. As
presented in Table 2, IVB cells express genes involved in
responses to hormonal stimuli at a greater level than AR-5,
whereas AR-5 cells express respiratory genes and cellular
stress response genes at a higher level than the IVB cells.
Link between CRH and mitochondrial genes
In mammals, the endocrine stress response is initiated
by activation of the HPA axis, which includes elevated
levels of hypothalamic CRH, which ultimately lead to
increased levels of circulating glucocorticoids. In the
periphery, glucocorticoids stimulate gluconeogenesis and
lipolysis to meet increased energy demands associated
with a stressful situation. To determine if there is any
connection between CRH and the differentially expressed
genes between AR-5 and IVB cell lines, genes listed in
the Table 2 were submitted to the STRING on-line data-
base analysis tool, which searches for physical and/orfunctional associations between enriched genes that have
been reported in the literature (Figure 4). Figure 4 shows
a strong association between the mitochondrial genes
(MT-ND1, MT-ND2, MT-ND3, MT-CO1, MT-CO2, MT-
CYB, Ndufa10, Ndufs1, Ndufv2), which are abundant in
AR-5 cells, and a strong association between genes in-
volved in CRH signaling and regulation (CRH, CRHR1,
CRHR2, CRHBP, glucocorticoid receptor (GR or Nr3c1)),
which are not differentially expressed. The figure also shows
that there is no direct connection between the mitochon-
drial genes and CRH or GR.
Although STRING did not reveal any direct associ-
ation between the mitochondrial genes and GR, gluco-
corticoids have been shown to have a profound impact
on mitochondrial functions. They can influence mito-
chondrial respiration, OXPHOS, ion transport, size and
mitochondrial copy number [17-20]. Also, there is evidence
to suggest that glucocorticoids modulate mitochondrial
transcription through GR activation [21]. The mitochon-
drial genome contains 6 GRE (glucocorticoid response
element)-like sequences, 2 in the displacement loop
(D-loop) (GREa, GREb), 3 in the MT-CO1 gene (GRE I-III)
and 1 in the MT-CO3 gene (GRE IV) [22]. The mitochon-
drial genome codes for 13 structural genes, all of which
are under the control of a single promoter, the D-loop
[23]. GR has been shown to bind to all six GRE sites [21
(Figure 4), 22 (Figure 2)]. GR binding to the two sites in
the D-loop may have a direct effect on gene transcription;
however, the mechanisms by which GREs I-IV, which are
present in the MT-CO1 and 3 coding regions, could regu-
late gene expression is more enigmatic. The majority of
these studies have been done in liver and muscle cells,
and we have not come across any studies that examined
effects of glucocorticoids on mitochondrial gene expres-
sion in the hypothalamus or amygdala.
Figure 4 Interaction between CRH and differentially expressed genes of AR-5 and IVB. Lines connecting each gene indicate either direct
physical interaction or indirect functional association. Thicker lines indicate stronger associations. Genes relatively abundant in AR-5 are outlined
in black, genes with an asterisk (*) are not differentially expressed, and the remaining genes are relatively abundant in IVBs. See Table 2 for
gene names.
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on mitochondrial gene expression, we performed a pre-
liminary experiment in which the cells were treated with
10-7 M dexamethasone (Dex, a synthetic glucocorticoid
agonist) for 6 hours We measured the change in expres-
sion of the six differentially expressed mitochondrial genes
identified in the array. Based on a sample size of 2 (n = 2),
we observed a Dex-induced increase in expression of 4
(out of 6) genes (MT-CYB, MT-ND1, MT-ND2 and MT-
ND3) in the AR-5 cell line and 2 genes (MT-CYB and
MT-ND3) in the IVB cell lines (data not shown). Given
that we only tested 6 genes and the mitochondrial genome
encodes 13 protein coding genes, one of our goals is to
study how the remaining mitochondrial genes respond toglucocorticoid treatment. Also, given that all the mito-
chondrial genes are transcribed as a polycistronic tran-
script, we expected all 6 genes to respond in the same
way. The fact that the genes had different responses, leads
us to infer that Dex may be influencing mitochondrial
RNA stability as well as mitochondrial transcription. We
will pursue these findings in future studies in which we
will take microarray, bioinformatic and biochemical ap-
proaches to elucidate mechanisms by which glucocorti-
coids alter mitochondrial gene expression.
Conclusion
Our goal was to identify genes that were differentially
expressed between AR-5 and IVBs. We hypothesized that
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http://www.biomedcentral.com/1471-2164/14/413transcription factors, coregulators and/or chromatin
modifying enzymes would be markedly different between
the two cell lines. We did find such genes to be differen-
tially expressed but the greatest difference was in six mito-
chondrial DNA-encoded genes, which are expressed in
much greater abundance in the amygdalar AR-5 cell line
as compared to the hypothalamic IVB cell line. It is not
clear why the expression of mitochondria-encoded genes
would be so different between two neuronal cell lines with
overlapping functions. One possibility could be that AR-5
cells have a higher energy demand than IVBs. This possi-
bility can be evaluated empirically in vivo, as can numer-
ous other questions that will arise from further analysis
of these data.
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